Lumen Bioscience
company
About
Lumen Bio discovers, develops, & manufactures biologic drugs and vaccine candidates for several prevalent, worldwide diseases.
- 51 - 100
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $1.80M
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Apr 1, 2017
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Lumen Bio is a clinical-stage biotechnology company developing topically and mucosally delivered biologic drugs to treat and prevent highly prevalent diseases.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$33M
Lumen Bioscience has raised a total of
$33M
in funding over 2 rounds. Their latest funding was raised on
Sep 24, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 24, 2020 | Grant | $4M | 1 |
U.S. Army Medical Research & Development Command
|
— | Detail |
| Sep 1, 2020 | Series B | $16M | 1 | — | — | Detail |
| Dec 5, 2017 | Grant | $1.80M | 1 |
US Department of Energy
|
— | Detail |
| Dec 5, 2017 | Series A | $11.20M | 1 |
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
3
Lumen Bioscience is funded by 3 investors.
U.S. Army Medical Research & Development Command
and US Department of Energy
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
U.S. Army Medical Research & Development Command
|
Yes | Grant |
|
US Department of Energy
|
Yes | Grant |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
